FIGURE LEGENDS
Figure 1. Classification and plasticity of ILCs.
Figure 2. Pathophysiology of the atopic dermatitis (AD) and the role of
ILC2s in AD.
Figure 3. Development of IgE-mediated food allergy in mucosal immune
system of the gut.
Figure 4. Role of ILC2 in eosinophilic eosophagitis (EoE).
REFERENCES
1. Boyce JA, Assa’ad A, Burks AW, Jones SM, Sampson HA, Wood RA, et al.
Guidelines for the Diagnosis and Management of Food Allergy in the
United States: Summary of the NIAID-Sponsored Expert Panel Report. J
Allergy Clin Immunol 2010; 126:1105-18.
2. Gupta RS, Springston EE, Warrier MR, Smith B, Kumar R, Pongracic J,
et al. The prevalence, severity, and distribution of childhood food
allergy in the United States. Pediatrics 2011; 128:e9-17.
3. Chafen JJ, Newberry SJ, Riedl MA, Bravata DM, Maglione M, Suttorp MJ,
et al. Diagnosing and managing common food allergies: a systematic
review. JAMA 2010; 303:1848-56.
4. Sicherer SH, Sampson HA. Food allergy: Epidemiology, pathogenesis,
diagnosis, and treatment. J Allergy Clin Immunol 2014; 133:291-307; quiz
8.
5. Brough HA, Liu AH, Sicherer S, Makinson K, Douiri A, Brown SJ, et al.
Atopic dermatitis increases the effect of exposure to peanut antigen in
dust on peanut sensitization and likely peanut allergy. J Allergy Clin
Immunol 2015; 135:164-70.
6. Galand C, Leyva-Castillo JM, Yoon J, Han A, Lee MS, McKenzie ANJ, et
al. IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by
targeting mast cells. J Allergy Clin Immunol 2016; 138:1356-66.
7. Lee JB, Chen CY, Liu B, Mugge L, Angkasekwinai P, Facchinetti V, et
al. IL-25 and CD4(+) TH2 cells enhance type 2 innate lymphoid
cell-derived IL-13 production, which promotes IgE-mediated experimental
food allergy. J Allergy Clin Immunol 2016; 137:1216-25 e5.
8. Herberth G, Daegelmann C, Roder S, Behrendt H, Kramer U, Borte M, et
al. IL-17E but not IL-17A is associated with allergic sensitization:
results from the LISA study. Pediatr Allergy Immunol 2010; 21:1086-90.
9. Wang YH, Liu YJ. Thymic stromal lymphopoietin, OX40-ligand, and
interleukin-25 in allergic responses. Clin Exp Allergy 2009; 39:798-806.
10. Noval Rivas M, Burton OT, Oettgen HC, Chatila T. IL-4 production by
group 2 innate lymphoid cells promotes food allergy by blocking
regulatory T-cell function. J Allergy Clin Immunol 2016; 138:801-11 e9.
11. Brough HA, Cousins DJ, Munteanu A, Wong YF, Sudra A, Makinson K, et
al. IL-9 is a key component of memory TH cell peanut-specific responses
from children with peanut allergy. J Allergy Clin Immunol 2014;
134:1329-38.e10.
12. Judd LM, Heine RG, Menheniott TR, Buzzelli J, O’Brien-Simpson N,
Pavlic D, et al. Elevated IL-33 expression is associated with pediatric
eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic
esophagitis development in mice. Am J Physiol Gastrointest Liver Physiol
2016; 310:G13-25.
13. Doherty TA, Baum R, Newbury RO, Yang T, Dohil R, Aquino M, et al.
Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic
esophagitis. J Allergy Clin Immunol 2015; 136:792-4 e3.
14. Artis D, Spits H. The biology of innate lymphoid cells. Nature 2015;
517:293-301.
15. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et
al. Innate lymphoid cells–a proposal for uniform nomenclature. Nat
Rev Immunol 2013; 13:145-9.
16. Shih HY, Sciume G, Poholek AC, Vahedi G, Hirahara K, Villarino AV,
et al. Transcriptional and epigenetic networks of helper T and innate
lymphoid cells. Immunol Rev 2014; 261:23-49.
17. van de Pavert SA, Olivier BJ, Goverse G, Vondenhoff MF, Greuter M,
Beke P, et al. Chemokine CXCL13 is essential for lymph node initiation
and is induced by retinoic acid and neuronal stimulation. Nat Immunol
2009; 10:1193-9.
18. Shikhagaie MM, Bjorklund AK, Mjosberg J, Erjefalt JS, Cornelissen
AS, Ros XR, et al. Neuropilin-1 Is Expressed on Lymphoid Tissue Residing
LTi-like Group 3 Innate Lymphoid Cells and Associated with Ectopic
Lymphoid Aggregates. Cell Rep 2017; 18:1761-73.
19. Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et
al. Innate Lymphoid Cells: 10 Years On. Cell 2018; 174:1054-66.
20. Kortekaas Krohn I, Shikhagaie MM, Golebski K, Bernink JH, Breynaert
C, Creyns B, et al. Emerging roles of innate lymphoid cells in
inflammatory diseases: Clinical implications. Allergy 2017.
21. Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, et
al. Intraepithelial type 1 innate lymphoid cells are a unique subset of
IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 2013;
38:769-81.
22. Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K,
et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal
tissues. Nat Immunol 2013; 14:221-9.
23. Bal SM, Bernink JH, Nagasawa M, Groot J, Shikhagaie MM, Golebski K,
et al. IL-1beta, IL-4 and IL-12 control the fate of group 2 innate
lymphoid cells in human airway inflammation in the lungs. Nat Immunol
2016; 17:636-45.
24. Jia Y, Fang X, Zhu X, Bai C, Zhu L, Jin M, et al. IL-13(+) Type 2
Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment
Response. Am J Respir Cell Mol Biol 2016; 55:675-83.
25. Chen R, Smith SG, Salter B, El-Gammal A, Oliveria JP, Obminski C, et
al. Allergen-induced Increases in Sputum Levels of Group 2 Innate
Lymphoid Cells in Subjects with Asthma. Am J Respir Crit Care Med 2017;
196:700-12.
26. Lao-Araya M, Steveling E, Scadding GW, Durham SR, Shamji MH.
Seasonal increases in peripheral innate lymphoid type 2 cells are
inhibited by subcutaneous grass pollen immunotherapy. J Allergy Clin
Immunol 2014; 134:1193-5 e4.
27. Saunders SP, Moran T, Floudas A, Wurlod F, Kaszlikowska A, Salimi M,
et al. Spontaneous atopic dermatitis is mediated by innate immunity,
with the secondary lung inflammation of the atopic march requiring
adaptive immunity. J Allergy Clin Immunol 2016; 137:482-91.
28. Mjösberg J, Spits H. Human innate lymphoid cells. Journal of Allergy
and Clinical Immunology 2016; 138:1265-76.
29. Buonocore S, Ahern PP, Uhlig HH, Ivanov, II, Littman DR, Maloy KJ,
et al. Innate lymphoid cells drive interleukin-23-dependent innate
intestinal pathology. Nature 2010; 464:1371-5.
30. Klose CS, Artis D. Innate lymphoid cells as regulators of immunity,
inflammation and tissue homeostasis. Nat Immunol 2016; 17:765-74.
31. Ruiter B, Patil SU, Shreffler WG. Vitamins A and D have antagonistic
effects on expression of effector cytokines and gut-homing integrin in
human innate lymphoid cells. Clin Exp Allergy 2015; 45:1214-25.
32. Komlosi ZI, Kovacs N, van de Veen W, Kirsch AI, Fahrner HB,
Wawrzyniak M, et al. Human CD40 ligand-expressing type 3 innate lymphoid
cells induce IL-10-producing immature transitional regulatory B cells. J
Allergy Clin Immunol 2018; 142:178-94 e11.
33. Palomares O, Ruckert B, Jartti T, Kucuksezer UC, Puhakka T, Gomez E,
et al. Induction and maintenance of allergen-specific FOXP3+ Treg cells
in human tonsils as potential first-line organs of oral tolerance. J
Allergy Clin Immunol 2012; 129:510-20, 20 e1-9.
34. Li J, Doty AL, Tang Y, Berrie D, Iqbal A, Tan SA, et al. Enrichment
of IL-17A(+) IFN-gamma(+) and IL-22(+) IFN-gamma(+) T cell subsets is
associated with reduction of NKp44(+) ILC3s in the terminal ileum of
Crohn’s disease patients. Clin Exp Immunol 2017; 190:143-53.
35. De Grove KC, Provoost S, Verhamme FM, Bracke KR, Joos GF, Maes T, et
al. Characterization and Quantification of Innate Lymphoid Cell Subsets
in Human Lung. PLoS One 2016; 11:e0145961.
36. Teunissen MBM, Munneke JM, Bernink JH, Spuls PI, Res PCM, Te Velde
A, et al. Composition of innate lymphoid cell subsets in the human skin:
enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis
patients. J Invest Dermatol 2014; 134:2351-60.
37. Gury-BenAri M, Thaiss CA, Serafini N, Winter DR, Giladi A,
Lara-Astiaso D, et al. The Spectrum and Regulatory Landscape of
Intestinal Innate Lymphoid Cells Are Shaped by the Microbiome. Cell
2016; 166:1231-46 e13.
38. Simoni Y, Fehlings M, Kloverpris HN, McGovern N, Koo SL, Loh CY, et
al. Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based
Heterogeneity in Phenotype and Frequency. Immunity 2017; 46:148-61.
39. Bal SM, Golebski K, Spits H. Plasticity of innate lymphoid cell
subsets. Nat Rev Immunol 2020; 20:552-65.
40. Klose CS, Kiss EA, Schwierzeck V, Ebert K, Hoyler T, d’Hargues Y, et
al. A T-bet gradient controls the fate and function of CCR6-RORgammat+
innate lymphoid cells. Nature 2013; 494:261-5.
41. Klose CSN, Flach M, Mohle L, Rogell L, Hoyler T, Ebert K, et al.
Differentiation of type 1 ILCs from a common progenitor to all
helper-like innate lymphoid cell lineages. Cell 2014; 157:340-56.
42. Bernink JH, Krabbendam L, Germar K, de Jong E, Gronke K,
Kofoed-Nielsen M, et al. Interleukin-12 and -23 Control Plasticity of
CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal
Lamina Propria. Immunity 2015; 43:146-60.
43. Abdallah F, Mijouin L, Pichon C. Skin Immune Landscape: Inside and
Outside the Organism. Mediators Inflamm 2017; 2017:5095293.
44. Mjosberg J, Spits H. Human innate lymphoid cells. J Allergy Clin
Immunol 2016; 138:1265-76.
45. Roediger B, Kyle R, Yip KH, Sumaria N, Guy TV, Kim BS, et al.
Cutaneous immunosurveillance and regulation of inflammation by group 2
innate lymphoid cells. Nat Immunol 2013; 14:564-73.
46. Villanova F, Flutter B, Tosi I, Grys K, Sreeneebus H, Perera GK, et
al. Characterization of innate lymphoid cells in human skin and blood
demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol
2014; 134:984-91.
47. Kobayashi T, Voisin B, Kim DY, Kennedy EA, Jo JH, Shih HY, et al.
Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells
Regulates Commensal Bacteria Equilibrium. Cell 2019; 176:982-97 e16.
48. Dyring-Andersen B, Geisler C, Agerbeck C, Lauritsen JP,
Gudjonsdottir SD, Skov L, et al. Increased number and frequency of group
3 innate lymphoid cells in nonlesional psoriatic skin. Br J Dermatol
2014; 170:609-16.
49. Munneke JM, Bjorklund AT, Mjosberg JM, Garming-Legert K, Bernink JH,
Blom B, et al. Activated innate lymphoid cells are associated with a
reduced susceptibility to graft-versus-host disease. Blood 2014;
124:812-21.
50. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG,
Doering TA, et al. Innate lymphoid cells promote lung-tissue homeostasis
after infection with influenza virus. Nat Immunol 2011; 12:1045-54.
51. Salimi M, Barlow JL, Saunders SP, Xue L, Gutowska-Owsiak D, Wang X,
et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in
atopic dermatitis. J Exp Med 2013; 210:2939-50.
52. Rak GD, Osborne LC, Siracusa MC, Kim BS, Wang K, Bayat A, et al.
IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound
Healing. J Invest Dermatol 2016; 136:487-96.
53. Li Z, Hodgkinson T, Gothard EJ, Boroumand S, Lamb R, Cummins I, et
al. Epidermal Notch1 recruits RORgamma(+) group 3 innate lymphoid cells
to orchestrate normal skin repair. Nat Commun 2016; 7:11394.
54. Tordesillas L, Goswami R, Benede S, Grishina G, Dunkin D, Jarvinen
KM, et al. Skin exposure promotes a Th2-dependent sensitization to
peanut allergens. J Clin Invest 2014; 124:4965-75.
55. Reese TA, Liang HE, Tager AM, Luster AD, Van Rooijen N, Voehringer
D, et al. Chitin induces accumulation in tissue of innate immune cells
associated with allergy. Nature 2007; 447:92-6.
56. Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg GF,
et al. TSLP elicits IL-33-independent innate lymphoid cell responses to
promote skin inflammation. Sci Transl Med 2013; 5:170ra16.
57. Sugita K, Altunbulakli C, Morita H, Sugita A, Kubo T, Kimura R, et
al. Human type 2 innate lymphoid cells disrupt skin keratinocyte tight
junction barrier by IL-13. Allergy 2019; 74:2534-7.
58. Imai Y, Yasuda K, Sakaguchi Y, Haneda T, Mizutani H, Yoshimoto T, et
al. Skin-specific expression of IL-33 activates group 2 innate lymphoid
cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl
Acad Sci U S A 2013; 110:13921-6.
59. Li M, Messaddeq N, Teletin M, Pasquali JL, Metzger D, Chambon P.
Retinoid X receptor ablation in adult mouse keratinocytes generates an
atopic dermatitis triggered by thymic stromal lymphopoietin. Proc Natl
Acad Sci U S A 2005; 102:14795-800.
60. Salimi M, Xue L, Jolin H, Hardman C, Cousins DJ, McKenzie AN, et al.
Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing
Type 2 Cytokine Production. J Immunol 2016; 196:45-54.
61. Chu DK, Llop-Guevara A, Walker TD, Flader K, Goncharova S, Boudreau
JE, et al. IL-33, but not thymic stromal lymphopoietin or IL-25, is
central to mite and peanut allergic sensitization. J Allergy Clin
Immunol 2013; 131:187-200 e1-8.
62. Leyva-Castillo JM, Galand C, Kam C, Burton O, Gurish M, Musser MA,
et al. Mechanical Skin Injury Promotes Food Anaphylaxis by Driving
Intestinal Mast Cell Expansion. Immunity 2019; 50:1262-75 e4.
63. Kurashima Y, Kiyono H. Mucosal Ecological Network of Epithelium and
Immune Cells for Gut Homeostasis and Tissue Healing. Annu Rev Immunol
2017; 35:119-47.
64. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M,
et al. Diversity of the human intestinal microbial flora. Science 2005;
308:1635-8.
65. Fuchs A, Colonna M. Innate lymphoid cells in homeostasis, infection,
chronic inflammation and tumors of the gastrointestinal tract. Curr Opin
Gastroenterol 2013; 29:581-7.
66. Hepworth MR, Fung TC, Masur SH, Kelsen JR, McConnell FM, Dubrot J,
et al. Immune tolerance. Group 3 innate lymphoid cells mediate
intestinal selection of commensal bacteria-specific CD4(+) T cells.
Science 2015; 348:1031-5.
67. Zhou L, Chu C, Teng F, Bessman NJ, Goc J, Santosa EK, et al. Innate
lymphoid cells support regulatory T cells in the intestine through
interleukin-2. Nature 2019; 568:405-9.
68. Melo-Gonzalez F, Hepworth MR. Functional and phenotypic
heterogeneity of group 3 innate lymphoid cells. Immunology 2017;
150:265-75.
69. Elson CO, Cong Y, Weaver CT, Schoeb TR, McClanahan TK, Fick RB, et
al. Monoclonal anti-interleukin 23 reverses active colitis in a T
cell-mediated model in mice. Gastroenterology 2007; 132:2359-70.
70. Rankin LC, Girard-Madoux MJ, Seillet C, Mielke LA, Kerdiles Y, Fenis
A, et al. Complementarity and redundancy of IL-22-producing innate
lymphoid cells. Nat Immunol 2016; 17:179-86.
71. Buela KA, Omenetti S, Pizarro TT. Cross-talk between type 3 innate
lymphoid cells and the gut microbiota in inflammatory bowel disease.
Curr Opin Gastroenterol 2015; 31:449-55.
72. Nussbaum JC, Van Dyken SJ, von Moltke J, Cheng LE, Mohapatra A,
Molofsky AB, et al. Type 2 innate lymphoid cells control eosinophil
homeostasis. Nature 2013; 502:245-8.
73. Monticelli LA, Osborne LC, Noti M, Tran SV, Zaiss DM, Artis D. IL-33
promotes an innate immune pathway of intestinal tissue protection
dependent on amphiregulin-EGFR interactions. Proc Natl Acad Sci U S A
2015; 112:10762-7.
74. Sampson HA. Food allergy. Part 1: immunopathogenesis and clinical
disorders. J Allergy Clin Immunol 1999; 103:717-28.
75. Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF,
et al. Randomized trial of peanut consumption in infants at risk for
peanut allergy. N Engl J Med 2015; 372:803-13.
76. Schulz O, Jaensson E, Persson EK, Liu X, Worbs T, Agace WW, et al.
Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in
lymph and serve classical dendritic cell functions. J Exp Med 2009;
206:3101-14.
77. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM,
Belkaid Y, et al. A functionally specialized population of mucosal
CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic
acid-dependent mechanism. J Exp Med 2007; 204:1757-64.
78. Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4+CD25+
regulatory T cells in children who have outgrown cow’s milk allergy. J
Exp Med 2004; 199:1679-88.
79. Hill DJ, Hosking CS, de Benedictis FM, Oranje AP, Diepgen TL,
Bauchau V, et al. Confirmation of the association between high levels of
immunoglobulin E food sensitization and eczema in infancy: an
international study. Clin Exp Allergy 2008; 38:161-8.
80. Lack G, Fox D, Northstone K, Golding J, Avon Longitudinal Study of
P, Children Study T. Factors associated with the development of peanut
allergy in childhood. N Engl J Med 2003; 348:977-85.
81. Noti M, Kim BS, Siracusa MC, Rak GD, Kubo M, Moghaddam AE, et al.
Exposure to food allergens through inflamed skin promotes intestinal
food allergy through the thymic stromal lymphopoietin-basophil axis. J
Allergy Clin Immunol 2014; 133:1390-9, 9 e1-6.
82. Wang YH, Ito T, Wang YH, Homey B, Watanabe N, Martin R, et al.
Maintenance and polarization of human TH2 central memory T cells by
thymic stromal lymphopoietin-activated dendritic cells. Immunity 2006;
24:827-38.
83. Shik D, Tomar S, Lee JB, Chen CY, Smith A, Wang YH. IL-9-producing
cells in the development of IgE-mediated food allergy. Semin
Immunopathol 2017; 39:69-77.
84. Lee JB. Regulation of IgE-Mediated Food Allergy by IL-9 Producing
Mucosal Mast Cells and Type 2 Innate Lymphoid Cells. Immune Netw 2016;
16:211-8.
85. Loh W, Tang MLK. The Epidemiology of Food Allergy in the Global
Context. Int J Environ Res Public Health 2018; 15.
86. Osborne NJ, Koplin JJ, Martin PE, Gurrin LC, Lowe AJ, Matheson MC,
et al. Prevalence of challenge-proven IgE-mediated food allergy using
population-based sampling and predetermined challenge criteria in
infants. J Allergy Clin Immunol 2011; 127:668-76 e1-2.
87. Xepapadaki P, Fiocchi A, Grabenhenrich L, Roberts G, Grimshaw KE,
Fiandor A, et al. Incidence and natural history of hen’s egg allergy in
the first 2 years of life-the EuroPrevall birth cohort study. Allergy
2016; 71:350-7.
88. Palmer G, Gabay C. Interleukin-33 biology with potential insights
into human diseases. Nat Rev Rheumatol 2011; 7:321-9.
89. Muto T, Fukuoka A, Kabashima K, Ziegler SF, Nakanishi K, Matsushita
K, et al. The role of basophils and proallergic cytokines, TSLP and
IL-33, in cutaneously sensitized food allergy. Int Immunol 2014;
26:539-49.
90. Burton OT, Medina Tamayo J, Stranks AJ, Miller S, Koleoglou KJ,
Weinberg EO, et al. IgE promotes type 2 innate lymphoid cells in murine
food allergy. Clin Exp Allergy 2018; 48:288-96.
91. Li J, Wang Y, Tang L, de Villiers WJ, Cohen D, Woodward J, et al.
Dietary medium-chain triglycerides promote oral allergic sensitization
and orally induced anaphylaxis to peanut protein in mice. J Allergy Clin
Immunol 2013; 131:442-50.
92. Lefrancais E, Duval A, Mirey E, Roga S, Espinosa E, Cayrol C, et al.
Central domain of IL-33 is cleaved by mast cell proteases for potent
activation of group-2 innate lymphoid cells. Proc Natl Acad Sci U S A
2014; 111:15502-7.
93. Hsu CL, Neilsen CV, Bryce PJ. IL-33 is produced by mast cells and
regulates IgE-dependent inflammation. PLoS One 2010; 5:e11944.
94. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et
al. Induction of colonic regulatory T cells by indigenous Clostridium
species. Science 2011; 331:337-41.
95. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, et
al. Treg induction by a rationally selected mixture of Clostridia
strains from the human microbiota. Nature 2013; 500:232-6.
96. Stefka AT, Feehley T, Tripathi P, Qiu J, McCoy K, Mazmanian SK, et
al. Commensal bacteria protect against food allergen sensitization. Proc
Natl Acad Sci U S A 2014; 111:13145-50.
97. Mortha A, Chudnovskiy A, Hashimoto D, Bogunovic M, Spencer SP,
Belkaid Y, et al. Microbiota-dependent crosstalk between macrophages and
ILC3 promotes intestinal homeostasis. Science 2014; 343:1249288.
98. Aceves SS. Eosinophilic esophagitis. Immunol Allergy Clin North Am
2015; 35:145-59.
99. Straumann A, Aceves SS, Blanchard C, Collins MH, Furuta GT, Hirano
I, et al. Pediatric and adult eosinophilic esophagitis: similarities and
differences. Allergy 2012; 67:477-90.
100. Assa’ad AH, Putnam PE, Collins MH, Akers RM, Jameson SC, Kirby CL,
et al. Pediatric patients with eosinophilic esophagitis: an 8-year
follow-up. J Allergy Clin Immunol 2007; 119:731-8.
101. Davis BP, Rothenberg ME. Emerging concepts of dietary therapy for
pediatric and adult eosinophilic esophagitis. Expert Rev Clin Immunol
2013; 9:285-7.
102. Spergel JM, Brown-Whitehorn TF, Beausoleil JL, Franciosi J, Shuker
M, Verma R, et al. 14 years of eosinophilic esophagitis: clinical
features and prognosis. J Pediatr Gastroenterol Nutr 2009; 48:30-6.
103. Maggadottir SM, Hill DA, Ruymann K, Brown-Whitehorn TF, Cianferoni
A, Shuker M, et al. Resolution of acute IgE-mediated allergy with
development of eosinophilic esophagitis triggered by the same food. J
Allergy Clin Immunol 2014; 133:1487-9, 9 e1.
104. Lucendo AJ, Arias A, Tenias JM. Relation between eosinophilic
esophagitis and oral immunotherapy for food allergy: a systematic review
with meta-analysis. Ann Allergy Asthma Immunol 2014; 113:624-9.
105. Ridolo E, De Angelis GL, Dall’aglio P. Eosinophilic esophagitis
after specific oral tolerance induction for egg protein. Ann Allergy
Asthma Immunol 2011; 106:73-4.
106. Clayton F, Fang JC, Gleich GJ, Lucendo AJ, Olalla JM, Vinson LA, et
al. Eosinophilic esophagitis in adults is associated with IgG4 and not
mediated by IgE. Gastroenterology 2014; 147:602-9.
107. Wright BL, Kulis M, Guo R, Orgel KA, Wolf WA, Burks AW, et al.
Food-specific IgG4 is associated with eosinophilic esophagitis. J
Allergy Clin Immunol 2016; 138:1190-2 e3.
108. Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA. The use of
skin prick tests and patch tests to identify causative foods in
eosinophilic esophagitis. J Allergy Clin Immunol 2002; 109:363-8.
109. Spergel JM, Brown-Whitehorn TF, Cianferoni A, Shuker M, Wang ML,
Verma R, et al. Identification of causative foods in children with
eosinophilic esophagitis treated with an elimination diet. J Allergy
Clin Immunol 2012; 130:461-7 e5.
110. Henderson CJ, Abonia JP, King EC, Putnam PE, Collins MH, Franciosi
JP, et al. Comparative dietary therapy effectiveness in remission of
pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2012;
129:1570-8.
111. Loizou D, Enav B, Komlodi-Pasztor E, Hider P, Kim-Chang J, Noonan
L, et al. A pilot study of omalizumab in eosinophilic esophagitis. PLoS
One 2015; 10:e0113483.
112. Katzka DA, Tadi R, Smyrk TC, Katarya E, Sharma A, Geno DM, et al.
Effects of topical steroids on tight junction proteins and spongiosis in
esophageal epithelia of patients with eosinophilic esophagitis. Clin
Gastroenterol Hepatol 2014; 12:1824-9 e1.
113. Blanchard C, Stucke EM, Burwinkel K, Caldwell JM, Collins MH,
Ahrens A, et al. Coordinate interaction between IL-13 and epithelial
differentiation cluster genes in eosinophilic esophagitis. J Immunol
2010; 184:4033-41.
114. Blanchard C, Mingler MK, Vicario M, Abonia JP, Wu YY, Lu TX, et al.
IL-13 involvement in eosinophilic esophagitis: transcriptome analysis
and reversibility with glucocorticoids. J Allergy Clin Immunol 2007;
120:1292-300.
115. Choi Y, Kim YM, Lee HR, Mun J, Sim S, Lee DH, et al. Eosinophil
extracellular traps activate type 2 innate lymphoid cells through
stimulating airway epithelium in severe asthma. Allergy 2020; 75:95-103.
116. Wilhelm C, Hirota K, Stieglitz B, Van Snick J, Tolaini M, Lahl K,
et al. An IL-9 fate reporter demonstrates the induction of an innate
IL-9 response in lung inflammation. Nat Immunol 2011; 12:1071-7.
117. Otani IM, Anilkumar AA, Newbury RO, Bhagat M, Beppu LY, Dohil R, et
al. Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in
pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol
2013; 131:1576-82.
118. Mjosberg J, Bernink J, Golebski K, Karrich JJ, Peters CP, Blom B,
et al. The transcription factor GATA3 is essential for the function of
human type 2 innate lymphoid cells. Immunity 2012; 37:649-59.
119. Weidinger S, Novak N. Atopic dermatitis. Lancet 2016; 387:1109-22.
120. Kim BS, Wang K, Siracusa MC, Saenz SA, Brestoff JR, Monticelli LA,
et al. Basophils promote innate lymphoid cell responses in inflamed
skin. J Immunol 2014; 193:3717-25.
121. Tojima I, Matsumoto K, Kikuoka H, Hara S, Yamamoto S, Shimizu S, et
al. Evidence for the induction of Th2 inflammation by group 2 innate
lymphoid cells in response to prostaglandin D2 and cysteinyl
leukotrienes in allergic rhinitis. Allergy 2019; 74:2417-26.
122. Walford HH, Lund SJ, Baum RE, White AA, Bergeron CM, Husseman J, et
al. Increased ILC2s in the eosinophilic nasal polyp endotype are
associated with corticosteroid responsiveness. Clin Immunol 2014;
155:126-35.
123. Yu QN, Guo YB, Li X, Li CL, Tan WP, Fan XL, et al. ILC2 frequency
and activity are inhibited by glucocorticoid treatment via STAT pathway
in patients with asthma. Allergy 2018; 73:1860-70.
124. Gauvreau GM, O’Byrne PM, Boulet LP, Wang Y, Cockcroft D, Bigler J,
et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic
responses. N Engl J Med 2014; 370:2102-10.
125. Kabata H, Moro K, Fukunaga K, Suzuki Y, Miyata J, Masaki K, et al.
Thymic stromal lymphopoietin induces corticosteroid resistance in
natural helper cells during airway inflammation. Nat Commun 2013;
4:2675.
126. Zhou W, Toki S, Zhang J, Goleniewksa K, Newcomb DC, Cephus JY, et
al. Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid
Cell Responses. Am J Respir Crit Care Med 2016; 193:31-42.
127. Lau EMT, Roche NA, Reddel HK. Therapeutic approaches to
asthma-chronic obstructive pulmonary disease overlap. Expert Rev Clin
Immunol 2017; 13:449-55.
128. Beck LA, Thaci D, Hamilton JD, Graham NM, Bieber T, Rocklin R, et
al. Dupilumab treatment in adults with moderate-to-severe atopic
dermatitis. N Engl J Med 2014; 371:130-9.
129. Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta
A, et al. Mepolizumab treatment in patients with severe eosinophilic
asthma. N Engl J Med 2014; 371:1198-207.
130. Thaci D, Simpson EL, Beck LA, Bieber T, Blauvelt A, Papp K, et al.
Efficacy and safety of dupilumab in adults with moderate-to-severe
atopic dermatitis inadequately controlled by topical treatments: a
randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet
2016; 387:40-52.
131. Wenzel S, Castro M, Corren J, Maspero J, Wang L, Zhang B, et al.
Dupilumab efficacy and safety in adults with uncontrolled persistent
asthma despite use of medium-to-high-dose inhaled corticosteroids plus a
long-acting beta2 agonist: a randomised double-blind placebo-controlled
pivotal phase 2b dose-ranging trial. Lancet 2016; 388:31-44.
132. Wojno ED, Monticelli LA, Tran SV, Alenghat T, Osborne LC, Thome JJ,
et al. The prostaglandin D(2) receptor CRTH2 regulates accumulation of
group 2 innate lymphoid cells in the inflamed lung. Mucosal Immunol
2015; 8:1313-23.
133. Schuligoi R, Sturm E, Luschnig P, Konya V, Philipose S, Sedej M, et
al. CRTH2 and D-type prostanoid receptor antagonists as novel
therapeutic agents for inflammatory diseases. Pharmacology 2010;
85:372-82.
134. Townley RG, Agrawal S. CRTH2 antagonists in the treatment of
allergic responses involving TH2 cells, basophils, and eosinophils. Ann
Allergy Asthma Immunol 2012; 109:365-74.
135. Doherty TA, Khorram N, Lund S, Mehta AK, Croft M, Broide DH. Lung
type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1,
which regulates TH2 cytokine production. J Allergy Clin Immunol 2013;
132:205-13.
136. Barnig C, Cernadas M, Dutile S, Liu X, Perrella MA, Kazani S, et
al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid
cell activation in asthma. Sci Transl Med 2013; 5:174ra26.
137. Planaguma A, Kazani S, Marigowda G, Haworth O, Mariani TJ, Israel
E, et al. Airway lipoxin A4 generation and lipoxin A4 receptor
expression are decreased in severe asthma. Am J Respir Crit Care Med
2008; 178:574-82.
138. Ye L, Pan J, Liang M, Pasha MA, Shen X, D’Souza SS, et al. A
critical role for c-Myc in group 2 innate lymphoid cell activation.
Allergy 2020; 75:841-52.
139. Wang S, Xia P, Chen Y, Qu Y, Xiong Z, Ye B, et al. Regulatory
Innate Lymphoid Cells Control Innate Intestinal Inflammation. Cell 2017;
171:201-16 e18.
140. Morita H, Kubo T, Ruckert B, Ravindran A, Soyka MB, Rinaldi AO, et
al. Induction of human regulatory innate lymphoid cells from group 2
innate lymphoid cells by retinoic acid. J Allergy Clin Immunol 2019;
143:2190-201 e9.
141. Golebski K, Layhadi JA, Sahiner U, Steveling E, Lenormand MM, Li
RCY, et al. Immunotherapy for upper airway disease generates
IL-10-producing KLRG1+ ILC2s that are associated with clinical benefit.
Immunity 2020.
142. Tamari M, Orimo K, Motomura K, Arae K, Matsuda A, Nakae S, et al.
The optimal age for epicutaneous sensitization following tape-stripping
in BALB/c mice. Allergol Int 2018; 67:380-7.
143. Gowthaman U, Chen JS, Zhang B, Flynn WF, Lu Y, Song W, et al.
Identification of a T follicular helper cell subset that drives
anaphylactic IgE. Science 2019; 365.